InMed Pharmaceuticals (IMLFF) Short Interest Ratio & Short Volume

Short interest is the volume of InMed Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 30th, investors have sold 53,300 shares of IMLFF short. Learn More on InMed Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMLFF shares currently have a short interest ratio of 4.0. Learn More on InMed Pharmaceuticals's short interest ratio.

InMed Pharmaceuticals saw a increase in short interest in the month of October. As of October 30th, there was short interest totaling 53,300 shares, an increase of 0.4% from the previous total of 53,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.15 billion), Aon plc ($3.50 billion), Snap Inc. ($3.18 billion), Analog Devices, Inc. ($2.90 billion), The Clorox Company ($2.87 billion), Uber Technologies, Inc. ($2.01 billion), The Kroger Co. ($1.86 billion), International Flavors & Fragrances Inc. ($1.80 billion), Moderna, Inc. ($1.80 billion), and Simon Property Group, Inc. ($1.72 billion). View all of the most shorted stocks.

Short selling IMLFF is an investing strategy that aims to generate trading profit from InMed Pharmaceuticals as its price is falling. IMLFF shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for InMed Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IMLFF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMLFF, twice per month. The most recent reporting period available is October, 30 2020.